Suchergebnisse - "Dutta, Ankit K"

PubPharm (13)

1

Long-Term Follow-Up Defines the Population That Benefits from Early Interception in a High-Risk Smoldering Multiple Myeloma Clinical Trial Using the Combination of Ixazomib, Lenalidomide, and Dexamethasone

enthalten in: bioRxiv.org | 2024

von Nadeem, O. | Aranha, M. | Redd, R. | +19

2

Genomic profiling of Mycosis Fungoides identifies patients at high risk of disease progression

enthalten in: Blood advances | 2024

von Fléchon, L. | Arib, I. | Dutta, A. | +32

3

MinimuMM-seq : Genome Sequencing of Circulating Tumor Cells for Minimally Invasive Molecular Characterization of Multiple Myeloma Pathology

enthalten in: Cancer discovery | 2023

von Dutta, A. | Alberge, J. | Lightbody, E. | +21

4

Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma

enthalten in: Cancer cell | 2022

von Sklavenitis-Pistofidis, R. | Aranha, M. | Redd, R. | +36

CommentIn: Cancer Cell. 2022 Nov 14;40(11):1270-1272. - PMID 36379204

5

Single-cell profiling of tumour evolution in multiple myeloma - opportunities for precision medicine

enthalten in: Nature reviews. Clinical oncology | 2022

von Dutta, A. | Alberge, J. | Sklavenitis-Pistofidis, R. | +3

6

Resilin-mimetics as a smart biomaterial platform for biomedical applications

enthalten in: Nature communications | 2021

von Balu, R. | Dutta, N. | Dutta, A. | +1

7

Subclonal evolution in disease progression from MGUS/SMM to multiple myeloma is characterised by clonal stability

enthalten in: Leukemia | 2019

von Dutta, A. | Fink, J. | Grady, J. | +5

8

Using genomics to better define high-risk MGUS/SMM patients

enthalten in: Oncotarget | 2018

von Dutta, A. | Hewett, D. | Fink, J. | +1

9

Cutting edge genomics reveal new insights into tumour development, disease progression and therapeutic impacts in multiple myeloma

enthalten in: British journal of haematology | 2017

von Dutta, A. | Hewett, D. | Fink, J. | +2

10

Cutting edge genomics reveal new insights into tumour development, disease progression and therapeutic impacts in multiple myeloma

enthalten in: British journal of haematology | 2017

von Dutta, A. | Hewett, D. | Fink, J. | +2